about
The ancient drug salicylate directly activates AMP-activated protein kinaseSerum aspirin esterase is strongly associated with glucose and lipids in healthy subjects: different association patterns in subjects with type 2 diabetes mellitus.Pharmacokinetics and molecular detoxicationAspirin and platelet adenosine diphosphate receptor antagonists in acute coronary syndromes and percutaneous coronary intervention: role in therapy and strategies to overcome resistance.Conjugation of cisplatin analogues and cyclooxygenase inhibitors to overcome cisplatin resistance.Neurological deficits induced by malathion, DEET, and permethrin, alone or in combination in adult rats.The role of human carboxylesterases in drug metabolism: have we overlooked their importance?The Small Molecule IMR-1 Inhibits the Notch Transcriptional Activation Complex to Suppress Tumorigenesis.Using a simple HPLC approach to identify the enzymatic products of UTL-5g, a small molecule TNF-α inhibitor, from porcine esterase and from rabbit esteraseRetinyl ester hydrolases and their roles in vitamin A homeostasis.Identifying determinants of variability to tailor aspirin therapy.D-amino acid-containing supramolecular nanofibers for potential cancer therapeutics.Pharmacokinetics of dinalbuphine sebacate and nalbuphine in Human after Intramuscular Injection of dinalbuphine sebacate in an Extended-Release Formulation.The design and bioactivation of presystemically stable prodrugs.Possible physiological roles of carboxylic ester hydrolases.Variability in the responsiveness to low-dose aspirin: pharmacological and disease-related mechanisms.Basic concepts in drug metabolism: Part I.Increased Body Exposure to New Anti-Trypanosomal Through Nanoencapsulation.Computational analysis reveal inhibitory action of nimbin against dengue viral envelope protein.Discovery of 3-alkoxyamino-5-(pyridin-2-ylamino)pyrazine-2-carbonitriles as selective, orally bioavailable CHK1 inhibitors.Nanoconjugate Platforms Development Based in Poly(β,L-Malic Acid) Methyl Esters for Tumor Drug DeliveryMultisite promiscuity in the processing of endogenous substrates by human carboxylesterase 1.Determination of the stability of drugs in plasma.Recovery of prostacyclin synthesis by rabbit aortic endothelium and other tissues after inhibition by aspirin.Identification of enzymes responsible for rifalazil metabolism in human liver microsomes.Salivary esterase activity and its association with the biodegradation of dental composites.Pharmacokinetics of rifapentine at 600, 900, and 1,200 mg during once-weekly tuberculosis therapy.The influence of age on salicylate pharmacokinetics in humans.Co-induction of methyltransferase Rv0560c by naphthoquinones and fibric acids suggests attenuation of isoprenoid quinone action in Mycobacterium tuberculosis.Synthesis and cellular characterization of various nano-assemblies of cell penetrating peptide-epirubicin-polyglutamate conjugates for the enhancement of antitumor activity.Reappraisal of the clinical pharmacology of low-dose aspirin by comparing novel direct and traditional indirect biomarkers of drug action.Pesticide residues variability and acute dietary risk assessment: a consumer perspective.Antagonism between salicylate and the cAMP signal controls yeast cell survival and growth recovery from quiescence.
P2860
Q24630758-1FAB4E67-2D70-40AC-B2FD-5DF9B973BFE5Q34060649-8A9CB072-6D67-4984-8DBE-E88A79745EA3Q34636589-DE2C07AD-30E0-459D-BB8E-EEC4FB153F9EQ34771381-AA96F0D2-EEEC-455F-AF0C-0D328E6017EEQ35334366-55C284BB-511D-4456-A36C-065B886443D6Q35624626-17265433-CD4E-439A-A88A-9A6511D7764AQ36066647-B114319E-C472-4756-8437-98DE61BB941BQ37014015-35109811-1828-4AC2-9A90-7A95ED50B992Q37314965-ABF86655-A3FE-4E93-8AC4-054605220728Q37876526-D453A442-BE75-46A4-A705-B9A2CCD8BE86Q38087384-E550E149-D1F4-4296-BC2D-E48D030CBB54Q38814443-B69676D3-C6CE-42A6-A040-4CA465BCD3BAQ39152323-1B85B23B-13D4-4A27-BF44-AE73CF8C14F4Q39567064-DA5F04BB-FFAF-439F-87C6-4C0ACC874A3BQ39642115-61CF49F1-EBFB-450A-BD78-3C22B3353F34Q39658839-C711966E-F0CB-4480-B8C2-C4B060677B57Q39679807-7846FDF8-978B-4F7D-A5CA-538C2B2FBA08Q40090893-D51B7DC0-D149-4998-93E1-63CCABFBBE46Q40127865-F713D28F-15E3-4935-8FC8-1A8398BEE3A5Q41761375-CE239062-F3E9-4197-ACA5-68FF14D9D33BQ41821522-7920A5E8-0926-4103-B85F-6109B04DC9BDQ41834963-A4292AF1-6282-40C1-8301-06332DAB6DB7Q42721800-8C69AB53-2CEB-4F0A-AC0B-6DB4B735373EQ42850026-483CF125-33C8-4359-A77F-0DF9FE41F6A5Q43505733-FAAB2EF2-13B1-47D4-ADFB-6CEB29F8E521Q44703219-3E960CF0-1813-47AA-AC94-CEFE35A4D5E8Q44764112-7BD5413B-62A7-43E5-B38F-50209B17E203Q45215629-410E8D7C-E8AA-4E53-9E9B-DCE798A494A7Q45220300-089F6131-284C-4E99-8E9B-7DE11DE71581Q48317053-E9169CE4-E32B-4684-A79D-5A3A3F102616Q51073878-1B912AB3-8B50-474E-A5C9-FEC48BC6064BQ52582454-0EF34004-F875-4EC5-ABCB-7832B89A0856Q55511178-971CE45E-BF9E-44F8-9FF3-4868FB640698
P2860
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Clinical significance of esterases in man.
@en
Clinical significance of esterases in man.
@nl
type
label
Clinical significance of esterases in man.
@en
Clinical significance of esterases in man.
@nl
prefLabel
Clinical significance of esterases in man.
@en
Clinical significance of esterases in man.
@nl
P1476
Clinical significance of esterases in man.
@en
P2093
F M Williams
P304
P356
10.2165/00003088-198510050-00002
P577
1985-09-01T00:00:00Z
P6179
1023404828